Wake Research partners with Carolina’s GI Research

Partnership to Increase Clinical Research Opportunities for Patients, Sponsors
in Greater-Triangle Area of North Carolina

(Raleigh, NC) – Raleigh-based Wake Research (Wake Research Associates, L.L.C.) announces a partnership with Carolina’s GI Research, with locations in Raleigh, Clayton, Cary and Wake Forest, North Carolina. The partnership brings the total number of Wake-owned and affiliated sites to 18, located in six states where Wake Research operates in the South, Mid-South and Southeastern United States.

“We at Carolina’s GI Research are very excited to partner with Wake Research,” said Dr. Subhash Gumber, Medical Director of Carolina’s GI Research. “Not only will it help us stay up-to-date in gastroenterology, but we will also be able to offer latest treatments to our patients.”

Wake Research is a wholly-owned integrated network of clinical research sites consisting of 100+ physicians and clinical Investigators based on large private practices and large multi-specialty healthcare institutions.

Wake Research conducts clinical trials in all major therapeutic areas with particular experience in internal medicine, dermatology, women’s health, metabolic diseases, gastroenterology, men’s health, neurology, pulmonology, rheumatology, vaccines, and women’s health trials. Wake Research conducts clinical trials in all phases (1 thru 4) and owns and operates Carolina phase 1, a dedicated phase 1 and a pharmacokinetic unit located in Raleigh, NC.

In addition to a proprietary research database of 585,000 clinical trial participants, Wake Research has its own, in-house agency, research, marketing & advertising, which leverages outreach to more than 9.7 million individuals in our communities.

About Wake Research

Wake Research is an organization of integrated investigational sites, committed to excellence, working closely with and meeting the needs of the biopharmaceutical, biotechnology, medical device and pharmaceutical industries. Wake Research sites are fully equipped to meet the needs of sponsors and CROs in the conduct of Phase I-IV clinical trials in a large variety of indications.

Wake Research is known for effectively combining strategic volunteer recruitment and retention with high-quality clinical trial conduct, using standardized operating procedures and centralized marketing and advertising to ensure rapid subject enrollment. Wake Research has conducted over 5,900 research studies for hundreds of pharmaceutical sponsors and CROs since 1984. Wake Research’s mission is to bring novel medications, biologics and device thru clinical research to as many people as possible while providing unparalleled service and exceptional value to clinical trial partners and stakeholders.